Évaluation de l’imatinib dans la prise en charge de la leucémie myéloïde chronique au Gabon À propos de dix-sept cas Volume 26, numéro 2, Avril-Mai- Juin. REVUE MEDICALE DE LIEGE. Cliquer ICI pour déclencher le téléchargement de l’article. COMMENT JE TRAITE LA LEUCEMIE MYELOIDE CHRONIQUE. Résumé La leucémie myéloïde chronique (LMC) est un modèle de cancérogenèse. Son pronostic a été exceptionnellement amélioré grâce.
|Published (Last):||12 October 2004|
|PDF File Size:||9.65 Mb|
|ePub File Size:||20.42 Mb|
|Price:||Free* [*Free Regsitration Required]|
Leucémie myéloïde chronique (LMC) · Groupe québécois de recherche en LMC-NMP
Chronic myeloid leukemia advances in biology and new approaches to treatment. S Af Med J. Indian J Hematol Blood Transfus.
Access to the PDF text. Myeeloide page Archives Contents list. Imatinib mesylate therapy in patients of chronic myeloid leukemia with Philadelphia chromosome positive: If you are a subscriber, please sign in ‘My Account’ at the top right of the screen.
Tyrosine kinase inhibitor TKI therapy imatinib, dasatinib, nilotinib, bosutinib, ponatinib has led to improved overall and disease-free survival of patients. Access to the text HTML. Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low and middle income countries.
Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reaction. Chronic myeloid leukaemia in central Africans. You can move this window by clicking on the headline. Molecular biology of bcr-abl1-positive CML. Contact Help Who are we?
There was a problem providing the content you requested
East Afr Med J. The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Access to the full text of this chroniqud requires a subscription.
Finally, the cgronique system undoubtedly plays a crucial function in the control of residual leukemic cells; this role should be specified in the future. New technologies digital PCR, high-throughput sequencing or NGS were developed to improve the performances of existing methods. Acellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. The Glivec international patient assistance programme: Clinical trials have validated TKI discontinuation strategies in patients with sustained deep molecular response.
Les inhibiteurs des kinases.
Clinical and pronognostic features of Nigerians with chronic myeloid leukemia. Hematologic and cytogenetic response to Imatinib mesylate in chronic myelogenous leukemia.
Leucémie myéloïde chronique | Blausen Medical
Chronic myeloid leukaemia at the Kenyatta National Hospital, Nairobi. Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia.
International recommendations facilitate the management of CML and treatment adjustments. Top of the page – Article Outline. Personal information regarding our website’s visitors, including their identity, is confidential.
Chronic myeloid leukaemia in South African blacks.
The persistence of TKI-refractory leukemic stem cells could explain this result. If you want to subscribe to this journal, see our rates You can purchase this myepoide in Pay Per View: For the remaining half of patients, the causes leading to the molecular relapse deserve to be further analyzed. N Engl J Med. Outline Masquer le plan. As per the Law relating to information storage and personal integrity, you have the right to oppose art 26 of that lawaccess art 34 of that law and rectify art 36 of that law your personal data.
You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
An experience from eastern India. A retrospective study of leukemia epidemiology in Northern Tunisia. New strategies to eradicate these residual cells by targeting the hematopoietic niche or directly the leukemic stem cells mye,oide being developed.